1. Academic Validation
  2. IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons

IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons

  • EMBO Rep. 2020 Mar 4;21(3):e49129. doi: 10.15252/embr.201949129.
Alexander D Fellows  # 1 Elena R Rhymes  # 1 Katherine L Gibbs 1 Linda Greensmith 1 Giampietro Schiavo 1 2 3
Affiliations

Affiliations

  • 1 Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • 2 UK Dementia Research Institute at UCL, London, UK.
  • 3 Discoveries Centre for Regenerative and Precision Medicine, University College London Campus, London, UK.
  • # Contributed equally.
Abstract

Signalling endosomes are essential for trafficking of activated ligand-receptor complexes and their distal signalling, ultimately leading to neuronal survival. Although deficits in signalling endosome transport have been linked to neurodegeneration, our understanding of the mechanisms controlling this process remains incomplete. Here, we describe a new modulator of signalling endosome trafficking, the insulin-like growth factor 1 receptor (IGF1R). We show that IGF1R inhibition increases the velocity of signalling endosomes in motor neuron axons, both in vitro and in vivo. This effect is specific, since IGF1R inhibition does not alter the axonal transport of mitochondria or lysosomes. Our results suggest that this change in trafficking is linked to the dynein adaptor bicaudal D1 (BICD1), as IGF1R inhibition results in an increase in the de novo synthesis of BICD1 in the axon of motor neurons. Finally, we found that IGF1R inhibition can improve the deficits in signalling endosome transport observed in a mouse model of amyotrophic lateral sclerosis (ALS). Taken together, these findings suggest that IGF1R inhibition may be a new therapeutic target for ALS.

Keywords

IGF1R; axonal transport; cytoplasmic dynein; signalling endosome; tetanus toxin.

Figures
Products